Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/33764
Appears in Collections: | Faculty of Social Sciences Journal Articles |
Peer Review Status: | Refereed |
Title: | Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members |
Author(s): | Parkes, Tessa Foster, Rebecca McAuley, Andrew Steven, Deborah Matheson, Catriona Baldacchino, Alex |
Contact Email: | t.s.parkes@stir.ac.uk |
Keywords: | chronic pain prescription opioids qualitative research overdose prevention naloxone |
Issue Date: | 17-Jan-2022 |
Date Deposited: | 20-Dec-2021 |
Citation: | Parkes T, Foster R, McAuley A, Steven D, Matheson C & Baldacchino A (2022) Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members. Drugs: Education, Prevention, and Policy. https://doi.org/10.1080/09687637.2021.2022100 |
Abstract: | It has been estimated that chronic non cancer pain (CNCP) affects more than 30% of people worldwide. Correspondingly, prescriptions for individuals experiencing CNCP have increased in recent years. While opioids can minimize pain, they also pose a risk of overdose. In 2019 in Scotland, prescription analgesics contributed to, or were implicated in, approximately 19% of drug related deaths. The experiences of those prescribed opioids for CNCP and family members, particularly their perceptions of overdose risk, are under-explored in the literature. This study aimed to address this gap by exploring how individuals and family members perceive the issue of overdose in relation to opioid analgesics, and their views of overdose prevention and potential interventions. Lived experiences from 12 individuals and family members living in Scotland were shared via in-depth qualitative interviews and analysed using NVivo and Framework. Coding was iterative and deductive. Analysis generated five themes: 1) living with pain and experiencing stigma; 2) taking more medication than prescribed; 3) side effects of medication; 4) overdose risk and prevention: the role of prescribers; and 5) attitudes towards naloxone to address overdose risk. Study findings have implications for the development of interventions and broader responses to reduce overdose risk among this group. |
DOI Link: | 10.1080/09687637.2021.2022100 |
Rights: | © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
Notes: | Output Status: Forthcoming/Available Online |
Licence URL(s): | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
09687637.2021.pdf | Fulltext - Published Version | 1.42 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
A file in this item is licensed under a Creative Commons License
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.